BR100 Increased By (0.44%)
BR30 Increased By (1.39%)
KSE100 Increased By (0.62%)
KSE30 Increased By (0.61%)
BECO 5.43 Decreased By ▼ -0.06 (-1.09%)
BML 55.69 Decreased By ▼ -1.07 (-1.89%)
BOP 35.38 Increased By ▲ 0.26 (0.74%)
CNERGY 8.20 Increased By ▲ 0.05 (0.61%)
DCL 11.55 Increased By ▲ 0.04 (0.35%)
FCCL 58.36 Increased By ▲ 1.61 (2.84%)
FCSC 5.12 Decreased By ▼ -0.03 (-0.58%)
FFL 17.84 Decreased By ▼ -0.04 (-0.22%)
FNEL 1.25 No Change ▼ 0.00 (0%)
HUMNL 11.07 Decreased By ▼ -0.05 (-0.45%)
KEL 8.75 Increased By ▲ 0.33 (3.92%)
KOSM 6.69 Increased By ▲ 0.11 (1.67%)
MLCF 107.15 Increased By ▲ 3.85 (3.73%)
NBP 201.73 Increased By ▲ 1.55 (0.77%)
PACE 11.30 Increased By ▲ 0.01 (0.09%)
PAEL 44.49 Increased By ▲ 1.02 (2.35%)
PIAHCLA 29.41 Increased By ▲ 1.92 (6.98%)
PIBTL 18.64 Increased By ▲ 0.94 (5.31%)
PPL 247.98 Increased By ▲ 3.66 (1.5%)
PRL 35.29 Decreased By ▼ -0.14 (-0.4%)
PTC 66.14 Increased By ▲ 0.79 (1.21%)
SEARL 95.49 Increased By ▲ 2.17 (2.33%)
SSGC 32.04 Decreased By ▼ -0.90 (-2.73%)
TELE 8.87 Decreased By ▼ -0.04 (-0.45%)
THCCL 66.61 Decreased By ▼ -0.11 (-0.16%)
TPLP 10.57 Decreased By ▼ -0.26 (-2.4%)
TREET 25.30 Increased By ▲ 0.18 (0.72%)
TRG 64.40 Decreased By ▼ -0.50 (-0.77%)
WAVES 10.90 Decreased By ▼ -0.03 (-0.27%)
WTL 1.26 Increased By ▲ 0.01 (0.8%)
World

Japan plans vaccine freezer buying binge as Tokyo reports record cases

  • Japan, with a population of 126 million, has agreements to buy a total of 290 million doses of vaccines from Pfizer Inc, AstraZeneca Plc and Moderna Inc, or enough for 145 million people.
Published December 10, 2020 Updated December 10, 2020 05:00pm
By

TOKYO: Japan said on Thursday it will buy 10,500 deep freezers to store novel coronavirus vaccines as it prepares for the "extraordinary task" of protecting its people, while the capital, Tokyo, reported a record number of new infections.

Japan, with a population of 126 million, has agreements to buy a total of 290 million doses of vaccines from Pfizer Inc, AstraZeneca Plc and Moderna Inc, or enough for 145 million people.

Pfizer's vaccines need to be kept at around minus 75 Celsius (minus 103 Fahrenheit), and Moderna's at about minus 20C, posing complex logistics challenges in rolling them out.

"An extraordinary task awaits us," Tokuaki Shobayashi, director general of the health service bureau at the ministry of health, told a media briefing on preparations.

A 90-year-old grandmother in Britain became the world's first person to receive a fully tested COVID-19 shot on Tuesday.

Though Japan has seen far fewer coronavirus cases than many Western countries, new infections are on the rise as colder weather keeps people indoors.

In all, it has recorded more than 165,000 infections and about 2,500 fatalities as of Wednesday, with Tokyo particularly hard hit.

The capital reported a record 602 new cases on Thursday, with nationwide daily infections at 2,078, according to public broadcaster NHK.

Top officials said the situation called for "maximum caution" as the spread showed little sign of easing.

BETTER LATE?

Defence Minister Nobuo Kishi this week ordered the military, known as the Self Defence Forces, to send nurses to a hard-hit city in Hokkaido prefecture in the north.

The health ministry said it is too early to say when Japan would get the vaccines, but AstraZeneca has announced that, of the 120 million doses to be allocated to Japan, 30 million would likely be supplied in the first quarter of 2021.

The government will oversee the vaccination operation and shoulder the costs. Front-line medical workers, the elderly and people with underlying health conditions will be given priority to get vaccinated.

Doctors and nurses will give the vaccines at clinics and hospitals, while facilities with parking lots such as gyms, shopping malls and community centres were being considered as vaccination venues, the ministry said.

Major Japanese manufactures of freezers include PHC, Nihon Freezer and Ebac. The government also plans to buy dry ice in bulk to maintain cold supply chains.

Infectious disease specialist Norio Sugaya said coming late to vaccination had its upsides.

"Truth be told, it would have been good if we had been able to have this started by the end of the year," Sugaya said.

"But we will be able to learn more about potential side effects and about how to build up the whole vaccination system that can maintain minus 70 Celsius."

Britain's medicines regulator has advised people with a history of significant allergies not to get the Pfizer vaccine after two people reported adverse reactions on the first day of its rollout there.

Comments

Comments are closed for this article.